Compile Data Set for Download or QSAR
maximum 50k data
Found 6 Enz. Inhib. hit(s) with all data for entry = 7793
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Drexel University

US Patent
LigandPNGBDBM218671(US9289400, ES609)
Affinity DataIC50:  293nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Drexel University

US Patent
LigandPNGBDBM218672(US9289400, PBZI)
Affinity DataIC50:  860nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Drexel University

US Patent
LigandPNGBDBM218672(US9289400, PBZI)
Affinity DataIC50:  1.61E+3nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Drexel University

US Patent
LigandPNGBDBM218671(US9289400, ES609)
Affinity DataIC50:  8.52E+3nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Drexel University

US Patent
LigandPNGBDBM218672(US9289400, PBZI)
Affinity DataIC50:  1.38E+4nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Drexel University

US Patent
LigandPNGBDBM218671(US9289400, ES609)
Affinity DataIC50:  3.59E+4nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In DepthDetails US Patent